BSE filing, NSE: RASIELEC. Summary written from the filing by ALFA Finder's alert engine.
Rasi Electrodes Ltd: key numbers
- Share price
- ₹12.50
- Market cap
- ₹38.91 Cr
- Revenue (annual)
- ₹72.02 Cr
- Net profit (annual)
- ₹3.52 Cr
- P/E (TTM)
- 10.8×Sector 52.0×
- Promoter holding
- 27.96%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rasi Electrodes Ltd
All →Rasi Electrodes Annual General Meeting
Rasi Electrodes filed certified minutes of its 32nd AGM held on 28 September 2026, signed by the Chairman. The minutes cover AGM proceedings, electronic voting and adoption of financial statements.
Rasi Electrodes Other Announcement
Rasi Electrodes Ltd has filed its shareholding pattern for the quarter ended September 30, 2026. This is a standard periodic regulatory disclosure of the company's capital structure.
Rasi Electrodes Annual General Meeting
Rasi Electrodes Ltd held its 32nd Annual General Meeting on September 28, 2026. Shareholders deliberated on four items including the declaration of a 10% dividend.
Rasi Electrodes Annual Report
Rasi Electrodes Ltd submitted its 32nd Annual Report for FY 2025-26. The company also announced an AGM on September 28, 2026, and a dividend of Rs.0.20 per share.
Rasi Electrodes Annual General Meeting
Rasi Electrodes Ltd. has issued the notice for its 32nd Annual General Meeting scheduled for September 28, 2026, to consider financial results and dividend declaration.
Rasi Electrodes Dividend
Rasi Electrodes Limited announced a final dividend of ₹0.20 per equity share for FY2026. The book closure for the dividend is scheduled from September 22 to September 28, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.